Talking about what others are afraid to say
The GLP-1 market has swept over the world like a new gold rush, but challenges remain, including high discontinuation rates as well as employers and insurers denying coverage. Is the …
The Future & Challenges Of The GLP-1 Market Read More
New data from McKesson Compile shows that nurse practitioners (NPs) and physician assistants (PAs) are playing an increasingly prominent role in the oncology treatment landscape. And few pharma companies may …
Pharma’s Oncology Targeting Model Is Missing Part of the Care Team Read More
Pharma and other healthcare companies love qualitative research. Advisory boards, focus groups, patient interviews, physician discussions, and ethnographic studies have become standard tools for gathering insights. The belief is simple: …
Why I Don’t Trust Qualitative Research in Healthcare Read More
According to a report from Stout, the oncology industry is entering a new era — one defined by rapid scientific innovation, rising patient demand, workforce shortages, and aggressive consolidation among …
Oncology in 2026: Why Cancer Care Is Becoming Bigger, More Consolidated, and More Personalized Read More
When you walk into a pharmacy to pick up a prescription, you’re participating in one of healthcare’s most common yet complex rituals. But how do patients actually feel about the …
Patient Perspectives on Prescription Medications and Affordability Read More
According to a JAMA study of 125,474 patients initiating GLP-1 RAs, 46.5% of patients with and 64.8% without type 2 diabetes discontinued within 1 year; 47.3% of patients with and …
Patient Experiences with GLP-1 Drugs: Weight Loss & Side Effects Read More
Sermo partnered with experts Dr. Murali Doraiswamy from Duke University School of Medicine and Dr. Lon Schneider from the University of Southern California to develop an in-depth survey on new Alzheimer’s treatments. Only …
Challenges of Anti-Amyloid Therapies in Alzheimer’s Disease: Neurologists’ Perspectives Read More
“A survey from Graphite clearly shows the pharma industry’s challenges as it tries to transition to a digital strategy. “Teams are struggling to measure the impact of digital solutions, limiting …
Significant Challenges Persist Around Executing Digital Strategies Successfully. Read More